logo

Quick Facts

Share

Novavax Inc. (NVAX) said Friday that partner, SK bioscience, has received a Post Approval Change Application approval from the Korean Ministry of Food and Drug Safety for Nuvaxovid (NVX-CoV2373) COVID-19 vaccine for active immunization to prevent COVID-19 caused by the SARS-CoV-2 in adolescents aged...

Humana Inc. (HUM) announced Friday that it will acquire substantially all of the assets of Inclusa, Inc., a Managed Care Organization or MCO, in Wisconsin that provides long-term care services and supports to approximately 16,600 older adults and adults with disabilities through the state's Family Care...

GrowGeneration Corp. (GRWG) announced Friday a series of organizational realignment in the areas of accounting and finance and corporate affairs as part of its broader efforts to more fully realize the longer-term opportunities by leveraging the deep talent that exists within GrowGen. This realignment...

Vontier Corp. (VNT) announced the appointment of Anshooman Aga as Chief Financial Officer, effective August 29, 2022. Aga succeeds David Naemura who will remain with the company through year end. Most recently, Aga served as Senior Vice President and CFO of Harsco Corp. from August 2021 through August...

PLx Pharma Inc. (PLXP) reported Friday a second-quarter net loss attributable to common shareholders of $11.56 million or $0.43 per share, narrower than $18.71 million or $0.79 per share in the prior-year quarter. Excluding items, adjusted loss for the quarter were $0.52 per share, compared to adjusted...

Aptinyx Inc. (APTX) said that a phase 2b study of NYX-2925 in Fibromyalgia did not achieve statistically significant separation from placebo on the study's primary endpoint, which assessed the change from baseline in average daily pain on the numeric rating scale or NRS during week 12. According to...

UNITY Biotechnology, Inc. (UBX) reported 12- and 18-week data from phase 2 BEHOLD study of UBX1325 in patients with diabetic macular edema. In the study, a single injection of UBX1325 led to a progressive, statistically significant, and clinically meaningful improvement in mean Best Corrected Visual...

Broadridge Financial Solutions, Inc. (BR) reported fourth quarter adjusted EPS of $2.65 compared to $2.19, a year ago. On average, five analysts polled by Thomson Reuters expected the company to report profit per share of $2.62, for the quarter. Analysts' estimates typically exclude special items. Net...

Health and wellness company Mannatech Inc. (MTEX) reported Friday that second-quarter net income plunged to $0.69 million or $0.34 per share from $2.13 million or $0.99 per share in the prior-year quarter. Net sales for the quarter declined 17.7 percent to $34.98 million from $42.50 million in the...

Drug major Pfizer Inc. (PFE) announced Friday positive top-line results from its pivotal U.S. Phase 3 study (NCT04382326) evaluating its 20-valent pneumococcal conjugate vaccine candidate or 20vPnC in infants. The trial was for the prevention of invasive pneumococcal disease or IPD caused by the 20...

Specialized materials firm Avient Corp. (AVNT) announced Friday it has entered into a definitive agreement to sell its Distribution business to an affiliate of H.I.G. Capital for $950 million in cash, subject to regulatory approval. The company noted that after-tax proceeds of approximately $750 million...

Cerevel Therapeutics Holdings, Inc. (CERE) announced the pricing of its underwritten public offering of 7.25 million shares of its common stock at a public offering price of $35.00 per share, or approximately $253.8 million of shares of common stock. Cerevel estimates that the net proceeds from the offering...

British drug maker GSK plc (GSK, GSK.L), in its statement on Zantac (ranitidine) litigation and N-nitrosodimethylamine or NDMA, said the U.S. and European regulators have concluded there is no evidence of a causal association between ranitidine therapy and the development of cancer. The company noted...

Mitsui & Co., Ltd (MITSF.PK, MITSY.PK), which currently holds 20% stake in Stanmore SMC Pty Ltd jointly with Mitsui & Co. (Australia) Ltd. or "MAL", said Friday that it has decided to sell all of its shares in SMC held by Mitsui and MAL to an Australian subsidiary of Stanmore Resources Limited, a coal...

Daiichi Sankyo and AstraZeneca's (AZN, AZN.L) Enhertu (fam-trastuzumab deruxtecan-nxki) has been approved in the U.S. for the treatment of adult patients with unresectable or metastatic non-small cell lung cancer or NSCLC whose tumors have activating HER2 (ERBB2) mutations, as detected by an FDA-approved...

Follow RTT